Atara Biotherapeutics, Inc.
USD11.17
+0.66 (+6.28%)
CEO
Anhco Nguyen
IPO Date
2014-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.60
Prev. Close
$10.51
Day Low
$10.47
Day High
$11.18
52W Low
$3.92
52W High
$19.14
Market Cap
$0.10B
Volume
0.06M
| 0 |
| $0.00 |
| 11 Jun 2026 | HEIDEN WILLIAM K | director | A-Award | Acquired | 12,000 | $0.00 |
| 11 Jun 2026 | Fust Matthew K | director | A-Award | Acquired | 12,000 | $0.00 |
| 11 Jun 2026 | Ciongoli Gregory Austin | director, 10 percent owner, other: See Remarks | A-Award | Acquired | 12,000 | $0.00 |
| 20 May 2026 | Nguyen AnhCo | director, officer: President and CEO | S-Sale | Disposed | 5,241 | $9.13 |
| 20 May 2026 | Grant-Huerta Yanina | Chief Accounting Officer | S-Sale | Disposed | 2,414 | $9.13 |
| 11 May 2026 | Panacea Innovation Ltd | 10 percent owner | S-Sale | Disposed | 313,446 | $10.10 |
| 11 May 2026 | EcoR1 Capital, LLC | 10 percent owner | P-Purchase | Acquired | 507,407 | $9.35 |
| 11 May 2026 | EcoR1 Capital, LLC | 10 percent owner | Disposed | 0 | $0.00 |